Emma has over 15 years’ experience as an equity analyst mainly across the biotech, pharma and med tech sectors, including more than 10 years as an analyst at Edison Group where she covered a range of pan-European mid-cap stocks.
Introducing the analyst: Emma Ulker
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE